Oculis Holding
OCS
9 hedge funds and large institutions have $32.1M invested in Oculis Holding in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.61% less ownership
Funds ownership: 8.63% → 8.02% (-0.61%)
17% less capital invested
Capital invested by funds: $38.5M → $32.1M (-$6.43M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$161K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$88.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$25.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$2.04M |
| 2 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$557K |
| 3 |
E
Ergoteles
New York
|
-$247K |
| 4 |
Barclays
London,
United Kingdom
|
-$44.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PBPIA
1
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
| $24.4M | -$2.04M | -162,442 | -7% |
|
|
NFGH
2
Nan Fung Group Holdings
Kai Tak,
Hong Kong
| $6.67M | -$557K | -44,416 | -7% |
|
|
CLOS
3
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $737K | – | – | – |
|
|
4
Bank of America
Charlotte,
North Carolina
| $185K | +$161K | +12,816 | +320% |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| $77.2K | +$88.1K | +7,021 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $22K | +$25.1K | +2,000 | +100,000% |
|
|
EC
7
Elequin Capital
New York
| $3.3K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2.24K | +$2.56K | +204 | New |
|
|
DCM
9
Dupont Capital Management
Wilmington,
Delaware
| $45 | – | – | – |
|
|
E
10
Ergoteles
New York
| – | -$247K | -20,000 | Closed |
|
|
11
Barclays
London,
United Kingdom
| – | -$44.4K | -3,602 | Closed |
|
OCS Hedge Fund Activity: Q3 2023 in Review
9 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Oculis Holding (OCS) for Q3 2023, worth a combined $32.1M — down 17% from $38.5M a quarter earlier.
Fund positioning in OCS was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, adding an estimated $161K. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $2.04M.
- 9 institutional investors held Oculis Holding (OCS) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $32.1M of Oculis Holding stock for Q3 2023, down 17% quarter-over-quarter.
- 2 funds opened new Oculis Holding positions in Q3 2023 and 2 closed out, a net change of 0 holders.
- The largest Oculis Holding buyer in Q3 2023 was Bank of America, an estimated $161K added.
- The largest Oculis Holding seller in Q3 2023 was Pivotal bioVenture Partners Investment Advisor, an estimated $2.04M sold.
Based on aggregated 13F filings for Q3 2023.